Jay Venkatesan, See Remarks at Angion Biomedica Corp. (ANGN), bought 11,313 shares at $1.25 ($14K) on 2022-05-25, disclosed to the SEC on 2022-05-27.
Open-market purchase of $14k ANGN by See Remarks. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| ANGN | BUY | 2021-12-29 | $1.5M | — | Filing → |
| ANGN | BUY | 2021-12-22 | $9K | — | Filing → |
| ANGN | BUY | 2021-12-20 | $177K | — | Filing → |